Humana Inc (HUM) Shares Sold by Bbva Compass Bancshares Inc.

Bbva Compass Bancshares Inc. lessened its holdings in shares of Humana Inc (NYSE:HUM) by 16.7% during the third quarter, HoldingsChannel reports. The institutional investor owned 916 shares of the insurance provider’s stock after selling 183 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Humana were worth $310,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. WESPAC Advisors LLC bought a new stake in shares of Humana during the 3rd quarter valued at $746,000. Meeder Asset Management Inc. bought a new stake in shares of Humana during the 3rd quarter valued at $8,380,000. Stratos Wealth Partners LTD. bought a new stake in shares of Humana during the 3rd quarter valued at $108,000. TD Asset Management Inc. boosted its holdings in shares of Humana by 3.1% during the 3rd quarter. TD Asset Management Inc. now owns 140,911 shares of the insurance provider’s stock valued at $47,701,000 after buying an additional 4,272 shares in the last quarter. Finally, Chicago Equity Partners LLC boosted its holdings in shares of Humana by 13.5% during the 3rd quarter. Chicago Equity Partners LLC now owns 52,008 shares of the insurance provider’s stock valued at $17,606,000 after buying an additional 6,170 shares in the last quarter. Hedge funds and other institutional investors own 92.62% of the company’s stock.

Shares of Humana stock opened at $338.95 on Friday. The stock has a market capitalization of $45.71 billion, a P/E ratio of 28.95, a PEG ratio of 1.65 and a beta of 1.03. Humana Inc has a 1 year low of $231.90 and a 1 year high of $355.88. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 0.47.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, November 7th. The insurance provider reported $4.58 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $4.29 by $0.29. The business had revenue of $14.21 billion for the quarter, compared to analysts’ expectations of $13.97 billion. Humana had a net margin of 2.48% and a return on equity of 17.43%. During the same quarter in the prior year, the business earned $3.39 EPS. As a group, analysts expect that Humana Inc will post 14.44 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, January 25th. Shareholders of record on Monday, December 31st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.59%. The ex-dividend date is Friday, December 28th. Humana’s dividend payout ratio is currently 17.08%.

A number of brokerages have recently commented on HUM. Morgan Stanley boosted their target price on shares of Humana from $400.00 to $418.00 and gave the company a “buy” rating in a report on Thursday. BMO Capital Markets set a $390.00 price target on shares of Humana and gave the stock a “buy” rating in a research note on Thursday. Royal Bank of Canada upped their price target on shares of Humana from $318.00 to $349.00 and gave the stock a “sector perform” rating in a research note on Thursday. Credit Suisse Group upped their price target on shares of Humana from $370.00 to $390.00 and gave the stock an “outperform” rating in a research note on Thursday. Finally, Bank of America upped their price target on shares of Humana from $400.00 to $415.00 and gave the stock a “buy” rating in a research note on Thursday. Seven equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Humana has an average rating of “Buy” and an average target price of $352.30.

In other Humana news, insider Elizabeth D. Bierbower sold 3,092 shares of the company’s stock in a transaction dated Thursday, August 16th. The shares were sold at an average price of $330.00, for a total transaction of $1,020,360.00. Following the transaction, the insider now owns 14,289 shares in the company, valued at approximately $4,715,370. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Bruce D. Broussard sold 18,000 shares of the company’s stock in a transaction dated Monday, September 10th. The shares were sold at an average price of $328.66, for a total transaction of $5,915,880.00. Following the transaction, the chief executive officer now owns 71,085 shares in the company, valued at approximately $23,362,796.10. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “Humana Inc (HUM) Shares Sold by Bbva Compass Bancshares Inc.” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://sportsperspectives.com/2018/11/10/humana-inc-hum-shares-sold-by-bbva-compass-bancshares-inc.html.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Read More: What is Cost of Debt?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply